Beta Bionics BBNX
NASDAQ BBNX
$17.42 -1.91 (-9.88%)
As of: Sep 9, 2026 · 3:59 PM EDT

Beta Bionics (BBNX) Share-based Compensation Growth (1y) (2024 - 2026)

Analysis

Beta Bionics (BBNX) Share-based Compensation Growth (1y) (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (1y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 18.31%
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 314.20%
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 45.35%
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn -78.13%
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn -15.28%
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 12.53%
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 10.53%
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn -13.91%
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 7.56%
10 Beta Bionics 786.45 Mn 605.96 Mn 18.90 Mn -2.99%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.99%
Mar 31, 2026 -15.18%
Dec 31, 2025 177.26%
Sep 30, 2025 242.37%
Jun 30, 2025 382.49%
Mar 31, 2025 505.49%
Dec 31, 2024 -70.17%